Cyclooxygenase-2 inhibitors delay relapse and reduce Prostate Specific Antigen (PSA) velocity in patients treated with radiotherapy for nonmetastatic prostate cancer: a pilot study

Introduction: A common treatment for localized prostate cancer (PCa) is radiotherapy; however, effectiveness is hampered because of toxicities and tumor resistance. Cyclooxygenase-2 (COX-2) inhibitors have been identified as potential agents that could improve treatment outcomes and have demonstrate...

Full description

Bibliographic Details
Main Authors: Liam King, David Christie, Devinder Arora, Shailendra Anoopkumar-Dukie
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Prostate International
Online Access:http://www.sciencedirect.com/science/article/pii/S2287888219300807